Melanotan II is a synthetic, cyclic analog of -MSH (-melanocyte-stimulating hormone) that activates melanocortin receptors most notably MC1R on skin melanocytes, driving melanin production (pigmentation)
After approval: Ongoing access continues through the membership, while licensed clinicians control continuation decisions, and the platform does not lock in future prescribing
Small blood spots often come from tiny vessels The skin has small surface blood vessels
This translates into better problem-solving skills, quicker decision-making, and improved overall cognitive function
Even if the presentation is ambiguous and you are not certain, providing a modest glucose source will not cause meaningful harm if blood glucose turns out to be normal
In March 2025, the FDA declared the end of the national shortage of approved GLP-1 drugs and gave online sellers until May 22 to withdraw mass-produced compounded versions from the market